Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Transplantation Proceedings
|
April 30, 2013
Kidney transplant recipients with functioning grafts for more than 15 years
A Celtik, N Alpay, A Celik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid
W C Zamboni, D I Lüftner, M J Egorin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2001
Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer
C W Vickery, J M Blazeby, T Conroy, et al.
Clinical Pharmacology and Therapeutics
|
October 5, 2007
Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects
A Kühne, O Sezer, U Heider, et al.
European Journal of Medical Research
|
March 6, 1999
Oxidant-induced lung injury in anticancer therapy
T Beinert, D Binder, M Stuschke, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 13, 2006
[Interdisciplinary guidelines on diagnosis and treatment for extracerebral amyloidoses--published by the German Society of Amyloid Diseases (www.amyloid.de)]
C Röcken, J Ernst, E Hund, et al.
British Journal of Haematology
|
March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life
M L Stead, J M Brown, G Velikova, et al.
British Journal of Cancer
|
January 27, 2011
Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21
E Friend, G Yadegarfar, C Byrne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
J M Blazeby, T Conroy, E Hammerlid, et al.
Leukemia
|
June 27, 2008
Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma
C Jakob, J Sterz, P Liebisch, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Transplantation Proceedings
|
April 30, 2013
Kidney transplant recipients with functioning grafts for more than 15 years
A Celtik, N Alpay, A Celik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid
W C Zamboni, D I Lüftner, M J Egorin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2001
Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer
C W Vickery, J M Blazeby, T Conroy, et al.
Clinical Pharmacology and Therapeutics
|
October 5, 2007
Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects
A Kühne, O Sezer, U Heider, et al.
European Journal of Medical Research
|
March 6, 1999
Oxidant-induced lung injury in anticancer therapy
T Beinert, D Binder, M Stuschke, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 13, 2006
[Interdisciplinary guidelines on diagnosis and treatment for extracerebral amyloidoses--published by the German Society of Amyloid Diseases (www.amyloid.de)]
C Röcken, J Ernst, E Hund, et al.
British Journal of Haematology
|
March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life
M L Stead, J M Brown, G Velikova, et al.
British Journal of Cancer
|
January 27, 2011
Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21
E Friend, G Yadegarfar, C Byrne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
J M Blazeby, T Conroy, E Hammerlid, et al.
Leukemia
|
June 27, 2008
Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma
C Jakob, J Sterz, P Liebisch, et al.
Page
of 12